FDA 483 - CSL Plasma Inc. - March 29, 2023

CSL Plasma Inc. in Hazel Crest, IL, underwent an FDA inspection from March 27-29, 2023. The inspection identified one significant observation regarding the firm's failure to investigate a donor death to determine if it was related to plasma donation. This indicates a lapse in adverse reaction investigation and record-keeping practices.